Edition:
India

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

1.87USD
2:03am IST
Change (% chg)

$0.05 (+2.75%)
Prev Close
$1.82
Open
$1.84
Day's High
$1.88
Day's Low
$1.83
Volume
10,962
Avg. Vol
41,339
52-wk High
$8.18
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Jun '20 0.00 -0.620
Mar '20 0.00 -0.485
FY 2019 Dec '19 0.00 -5.379
Sep '19 0.00 -1.010
Jun '19 0.00 -1.541
Mar '19 92.36 -0.835
FY 2018 Dec '18 0.00 -2.144
Sep '18 0.00 -2.134
Jun '18 0.00 -2.231
Mar '18 0.00 -1.959
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 33.53
P/E High - Last 5 Yrs. -- 40.50 45.20
P/E Low - Last 5 Yrs. -- 23.86 24.26
Beta -- 0.91 0.90
Price to Sales (TTM) 15.98 3.99 5.69
Price to Book (MRQ) 3.32 4.97 5.07
Price to Tangible Book (MRQ) 3.32 5.74 6.50
Price to Cash Flow (TTM) -- 23.03 23.51
% Owned Institutions -- 0.87 1.73

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.49
Dividend Yield - 5 Year Avg -- 1.56 1.51
Dividend 5 Year Growth Rate -- 4.28 5.14
Payout Ratio(TTM) -- 45.75 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 2.37 10.57
Sales (TTM) vs TTM 1 Yr. Ago 4,341.80 4.65 5.71
Sales - 5 Yr. Growth Rate -- 9.86 10.05
EPS (MRQ) vs Qtr. 1 Yr. Ago -104.48 16.29 20.17
EPS (TTM) vs TTM 1 Yr. Ago 81.78 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.10 14.97

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.33
Current Ratio (MRQ) 18.10 3.05 3.16
LT Debt to Equity (MRQ) 15.50 8.79 11.31
Total Debt to Equity (MRQ) 15.50 12.59 15.51
Interest Coverage (TTM) -15.86 41.12 36.66

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.55 54.39
Gross Margin - 5 Yr. Avg. -- 52.05 52.27
EBITD Margin (TTM) -156.26 -- --
EBITD - 5 Yr. Avg -- 18.46 11.96
Operating Margin (TTM) -157.49 14.38 5.41
Operating Margin - 5 Yr. Avg. -- 14.55 7.51
Pre-Tax Margin (TTM) -160.59 14.90 6.29
Pre-Tax Margin - 5 Yr. Avg. -- 14.98 8.02
Net Profit Margin (TTM) -160.59 11.09 2.52
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.24
Effective Tax Rate (TTM) -- 23.42 23.33
Effective Tax Rate - 5 Yr. Avg. -- 23.64 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 978,598,613 879,042,975
Net Income/Employee (TTM) -- 116,081,974 104,231,326
Receivable Turnover (TTM) 89.37 5.78 5.98
Inventory Turnover (TTM) -- 2.66 3.45
Asset Turnover (TTM) 0.19 0.98 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 11.90 11.45
Return on Assets - 5 Yr. Avg. -- 13.16 12.56
Return on Investment (TTM) -31.58 15.42 14.93
Return on Investment - 5 Yr. Avg. -- 17.10 16.29
Return on Equity (TTM) -37.22 16.77 16.49
Return on Equity - 5 Yr. Avg. -- 18.03 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 92.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 18.68 19.54 89 21
13 Week 12.14 9.63 80 38
26 Week -- -- -- 35
52 Week -- -- -- 14
YTD -- -- -- 27
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.